HK Stock Connect Daily Report: Southbound Capital Continued Net Inflow of HK$1.193 Billion, with LYGEND RESOURCE's (02245.HK) A-Share IPO Subscription Officially Launched - 20260918

I. Market Overview

On September 18, 2026, the three major Hong Kong stock indices rebounded collectively, with the Hang Seng Index up 0.60%, the Hang Seng TECH Index surging 2.20%, and the Hang Seng China Enterprises Index up 0.61%. The Hang Seng Index's full-day total market turnover was 266.5 billion HKD.

On the board, among Stock Connect constituent stocks, XIZHI TECH-P soared 22.61%, with some optical communications concept stocks moving higher; YUNJI surged 21.78%, with robot concept stocks strong on the dual catalysts of Tesla's Optimus factory audits in China and policy financing; AXERA surged 16.60% as the launch of its new M9 series products and the mass production of the M57 landed simultaneously, and the company's intelligent driving and edge AI businesses are expected to pick up as growth drivers; 160 HEALTH plunged 26.16%, with its share price having retraced more than 90% from this year's March high, hitting a record low; DELTON fell 7.88%, with cornerstone investors' shares unlocking from next Monday.

Southbound capital recorded net buying of HK$1.193 billion on the day. Of this, Stock Connect (Shanghai) recorded net buying of HK$17 million, and Stock Connect (Shenzhen) recorded net selling of HK$1.176 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

IV. Industry and Corporate Updates

1. Z.AI Completes the Placing of 21.965 Million New H Shares and the Issue of Convertible Bonds with an Aggregate Principal Amount of RMB20.14 Billion

On September 18, Z.AI (02513.HK) published an announcement that all the conditions precedent to the placing under the placing agreement had been fulfilled, and the placing was completed on September 16, 2026. The company successfully allotted and issued a total of 21.965 million new H shares to no fewer than 6 placees at the placing price of HK$714.00 per share, accounting for about 4.50% of the total number of issued shares as enlarged by the allotment and issue of the placing shares. The gross proceeds from the placing totaled about HK$15.683 billion, with net proceeds of about HK$15.664 billion. At the same time, bonds with an aggregate principal amount of RMB20.14 billion were completed for issue on September 18, with gross proceeds from the issue of the bonds of about US$3.016 billion and net proceeds of about US$3.011 billion

2. China Resources Pharmaceutical Commercial and SBP GROUP Sign a Strategic Cooperation Agreement, Targeting a Cooperation Scale of RMB10 Billion

On September 18, CHINARES PHARMA (03320.HK) announced that its China Resources Pharmaceutical Commercial and SBP GROUP (01177.HK) signed a strategic cooperation agreement. According to the announcement, the two parties will deepen cooperation in areas such as pharmaceutical commercial distribution, supply chain coordination, drug development, market access, DTP pharmacies and patient disease management, and jointly build a new type of industry-commerce partnership featuring R&D moving upstream, coordinated launch and an end-to-end connected commercialization chain. The two parties said the cooperation aims to accelerate the transformation of innovative outcomes, improve the accessibility of quality drugs and patients' medication experience, and achieve the strategic goal of a cooperation scale of RMB10 billion.

Reason for selection: Two Stock Connect targets signed a large-scale strategic cooperation agreement, covering end-to-end cooperation in pharmaceutical distribution, R&D, market access and other areas.

3. XUNCE Enters into a Memorandum of Cooperation with GP Capital to Explore an AI-Native, Token-Native Portfolio Ecosystem

On September 18, XUNCE (03317.HK) entered into a memorandum of cooperation with GP Capital, and the two parties will jointly explore building an AI-native, Token-native portfolio ecosystem. On the same day, LCC TECHNOLOGIES, a subsidiary of XTALPI (02228.HK), entered into a drug discovery cooperation agreement with Stanford University; GENSCRIPT BIO (01548.HK) reached cooperation with Lilly TuneLab™.

Reason for selection: Stock Connect targets intensively reached cooperation in the AI and biotechnology fields, a major strategic cooperation event.

4. LYGEND RESOURCE's A-Share IPO Subscription Officially Launched, at an Issue Price of RMB21.23 per Share

On September 18, LYGEND RESOURCE (02245.HK) officially opened its A-share subscription, at an issue price of RMB21.23 per share, and is about to list on the main board of the Shenzhen Stock Exchange. According to the prospectus, benefiting from the recovery in nickel prices, the gradual release of newly built smelting capacity and the continued expansion of downstream market demand, the company expects net profit attributable to owners of the parent company for the nine months ended September 30, 2026 to be about RMB3.15 billion to RMB3.25 billion, up about 54.0% to 58.9% year on year. LYGEND RESOURCE is a Stock Connect target.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.